Publication | Closed Access

Results of a Phase 1/2 Study in Metastatic Renal Cell Carcinoma Patients Treated with a Patient-specific Adjuvant Multi-peptide Vaccine after Resection of Metastases

Phase 1/2UrologyTumor ImmunologySurgical OncologyGenitourinary CancerImmunologyVaccine TrialTherapeutic VaccineImmune Checkpoint InhibitorImmunotherapeuticsImmunotherapyMedicine